Like its English-language predecessor, which launched in 2016, this Spanish-language patient community from MyHealthTeam is ...

Industry Veterans Appointed to Drive Strategic Vision of the Specialized Investment FundBOSTON, Oct. 16, 2024 (GLOBE NEWSWIRE) -- NYBC Ventures LLC (“NYBC Ventures”), a specialized fund focused on ...

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected ...

Despite a 7% YTD gain, IBB ETF has underperformed the S&P 500, which is up 21%, and shows negative alpha. Read more on IBB ...

The outcome of the 2024 U.S. presidential election is poised to affect the biotechnology sector, as both major parties present policy proposals that could reshape drug pricing, regulation, and ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation ...

In a year that has seen an approval and a raft of readouts for metabolic dysfunction-associated steatohepatitis (MASH), ...

Vaccine biotech Gritstone bio is filing for bankruptcy while securing a stalking horse bid from an unnamed party, which the ...

This partnership is supported by Lilly’s external biotech collaboration unit ... The tech has previously attracted big pharma ...

Biotechnology company Purespring Therapeutics has raised about $105 million to fund its development of gene therapies for diseases of the kidney.

Arcus Biosciences (RCUS) has received a new Buy rating, initiated by Wells Fargo analyst, Eva Fortea Verdejo. Eva Fortea Verdejo’s rating ...